La Scola B, Raoult D
Unité des Rickettsies, Centre National de la Recherche Scientifique: EP J 0054, Faculté de médecine, Marseille, France.
J Clin Microbiol. 1996 Nov;34(11):2722-7. doi: 10.1128/jcm.34.11.2722-2727.1996.
Rickettsia conorii, an obligate intracellular bacterium that infects vascular endothelial cells, is the etiologic agent of Mediterranean spotted fever. We correlated the results of 205 R. conorii blood and skin cultures for 157 patients and the results of 48 detections of R. conorii in circulating endothelial cells (CEC) for 41 patients with relevant serological, clinical, and therapeutic data. R. conorii was cultured from 40% of patients and 29.8% of samples. R. conorii was detected in CEC in 50% of samples, representing 46.2% of patients. When these calculations were limited to the samples from untreated patients prior to their seroconversion to R. conorii, the sensitivity of culture was 59%, whereas it remained at 50% for detection in CEC. We also performed PCRs for the detection of R. conorii on eight shell vial supernatants from positive cultures and on 43 blood samples. Only nonfrozen supernatants from fresh cultures were positive. The methods described in this report are suitable for use in all laboratories. Our findings suggest that for samples to be suitable for culture they must be collected prior to the initiation of an antibiotic regimen, as early as possible in the course of the disease, and be inoculated onto shell vials with minimal delay, if R. conorii is to be successfully isolated. For patients who have been treated or who have a delayed diagnosis, detection of R. conorii in CEC remains helpful.
康氏立克次体是一种专性细胞内细菌,可感染血管内皮细胞,是地中海斑疹热的病原体。我们将157例患者的205份康氏立克次体血液和皮肤培养结果,与41例患者循环内皮细胞(CEC)中48次康氏立克次体检测结果,与相关血清学、临床和治疗数据进行了关联分析。40%的患者和29.8%的样本培养出了康氏立克次体。50%的样本在CEC中检测到康氏立克次体,占患者的46.2%。当这些计算仅限于血清转化为康氏立克次体之前未治疗患者的样本时,培养的敏感性为59%,而CEC检测的敏感性仍为50%。我们还对来自阳性培养物的8份空斑小管上清液和43份血液样本进行了检测康氏立克次体的PCR。只有新鲜培养物的非冷冻上清液呈阳性。本报告中描述的方法适用于所有实验室。我们的研究结果表明,如果要成功分离康氏立克次体,样本要适合培养,必须在抗生素治疗开始前、疾病过程中尽早采集,并尽快接种到空斑小管上。对于已经接受治疗或诊断延迟的患者,检测CEC中的康氏立克次体仍然有帮助。